These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5110584)

  • 21. Characterization of sheep antibodies involved in precipitate formation with surface antigens of Fasciola hepatica in vitro.
    Sandeman RM; Howell MJ
    Int J Parasitol; 1982 Oct; 12(5):467-71. PubMed ID: 6815122
    [No Abstract]   [Full Text] [Related]  

  • 22. Fasciola hepatica: antibody levels in sheep serum before and after treatment with anthelmintic.
    Hanna RE; Hughes DL; Taylor SM
    Res Vet Sci; 1982 Nov; 33(3):328-32. PubMed ID: 6760303
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on emetine, an 'acute' fasciolicide.
    Grant MS; Jaggers SE
    Res Vet Sci; 1969 Mar; 10(2):197-202. PubMed ID: 5818036
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathological and immunohistochemical study of the liver and hepatic lymph nodes of sheep chronically reinfected with Fasciola hepatica, with or without triclabendazole treatment.
    Pérez J; Ortega J; Moreno T; Morrondo P; López-Sández C; Martínez-Moreno A
    J Comp Pathol; 2002 Jul; 127(1):30-6. PubMed ID: 12354543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasciola hepatica L. and fascioliasis: physiological, biochemical, pathogenic, immunologic, and diagnostic aspects.
    Locatelli A; Simonic T
    Folia Vet Lat; 1974 Jan; 4(1):43-70. PubMed ID: 4603539
    [No Abstract]   [Full Text] [Related]  

  • 26. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Taenia hydatigena infection on existing and concurrent infections of Fasciola hepatica in sheep.
    Campbell NJ; Dineen JK; Kelly JD
    Res Vet Sci; 1979 May; 26(3):391-3. PubMed ID: 515530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stimulation of resistance in sheep to Fasciola hepatica by infection with Cysticercus tenuicollis.
    Campbell NJ; Kelly JD; Townsend RB; Dineen JK
    Int J Parasitol; 1977 Oct; 7(5):347-51. PubMed ID: 924720
    [No Abstract]   [Full Text] [Related]  

  • 30. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of peritoneal macrophage immunophenotype in sheep experimentally infected with Fasciola hepatica.
    Ruiz-Campillo MT; Molina-Hernández V; Pérez J; Pacheco IL; Pérez R; Escamilla A; Martínez-Moreno FJ; Martínez-Moreno A; Zafra R
    Vet Parasitol; 2018 Jun; 257():34-39. PubMed ID: 29907190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to demonstrate resistance in goats, sheep and cattle to Fasciola hepatica after infection with Cysticercus tenuicollis.
    Hughes DL; Harness E; Doy TG
    Res Vet Sci; 1978 Nov; 25(3):356-9. PubMed ID: 749087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasciola hepatica: immunoprecipitation analysis of biosynthetically labelled antigens using sera from infected sheep.
    Sexton JL; Milner AR; Campbell NJ
    Parasite Immunol; 1991 Jan; 13(1):105-8. PubMed ID: 1707510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of resistance to Fasciola hepatica infection in sheep by a regime involving the use of the immunomodulatory compound L tetramisole (levamisole).
    Mitchell GB; Armour J
    Res Vet Sci; 1981 May; 30(3):343-8. PubMed ID: 7255928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response of sheep to Fasciola hepatica infection.
    Movsesijan M; Jovanović
    Res Vet Sci; 1975 Mar; 18(2):171-4. PubMed ID: 1093243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses of Fasciola hepatica infected sheep to various infection levels.
    Chauvin A; Moreau E; Boulard C
    Vet Res; 2001; 32(1):87-92. PubMed ID: 11254181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
    Mezo M; González-Warleta M; Carro C; Ubeira FM
    J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on experimental infections with Fasciola hepatica, with particular reference to acute fascioliasis in sheep.
    Boray JC
    Ann Trop Med Parasitol; 1967 Dec; 61(4):439-50. PubMed ID: 5634134
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution of Foxp3
    Escamilla A; Zafra R; Pérez J; McNeilly TN; Pacheco IL; Buffoni L; Martínez-Moreno FJ; Molina-Hernández V; Martínez-Moreno A
    Vet Parasitol; 2016 Oct; 230():14-19. PubMed ID: 27884436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.